Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann M Decker

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
ACS Chemical Neuroscience|February 3, 2015
Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptorDavid A Perrey, Nadezhda A German, Ann M Decker, et al.
Oncotarget|March 31, 2016
Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrowYounghun Jung, Ann M Decker, Jingcheng Wang, et al.
Journal of Cellular Biochemistry|October 19, 2016
Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular DormancyFrank C Cackowski, Matthew R Eber, James Rhee, et al.
Journal of Medicinal Chemistry|July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Journal of Medicinal Chemistry|August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.
Clinical Implant Dentistry and Related Research|March 11, 2024
Mucosal cyst aspiration in conjunction with maxillary sinus elevation: A clinical cohort studyTiziano Testori, Riccardo Scaini, Matteo Deflorian, et al.
ACS Chemical Neuroscience|July 1, 2016
Identification of 2-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)tricyclo[3.3.1.13,7]decane-2-carboxylic Acid (NTRC-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2James B Thomas, Mélanie Vivancos, Angela M Giddings, et al.
Neuropharmacology|October 10, 2017
Fluorinated phenmetrazine "legal highs" act as substrates for high-affinity monoamine transporters of the SLC6 familyFelix P Mayer, Nadine V Burchardt, Ann M Decker, et al.
Journal of Medicinal Chemistry|October 14, 2009
Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addictionF Ivy Carroll, Bruce E Blough, Philip Abraham, et al.
The Prostate|August 27, 2019
Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancerFrank C Cackowski, Yugang Wang, Joseph T Decker, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
ACS Chemical Neuroscience|February 3, 2015
Effect of 1-substitution on tetrahydroisoquinolines as selective antagonists for the orexin-1 receptorDavid A Perrey, Nadezhda A German, Ann M Decker, et al.
Oncotarget|March 31, 2016
Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrowYounghun Jung, Ann M Decker, Jingcheng Wang, et al.
Journal of Cellular Biochemistry|October 19, 2016
Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular DormancyFrank C Cackowski, Matthew R Eber, James Rhee, et al.
Journal of Medicinal Chemistry|July 24, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)Chad M Kormos, Pauline W Ondachi, Scott P Runyon, et al.
Journal of Medicinal Chemistry|August 18, 2018
Potent and Selective Tetrahydroisoquinoline Kappa Opioid Receptor Antagonists of Lead Compound (3 R)-7-Hydroxy- N-[(1 S)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (PDTic)Pauline W Ondachi, Chad M Kormos, Scott P Runyon, et al.
Clinical Implant Dentistry and Related Research|March 11, 2024
Mucosal cyst aspiration in conjunction with maxillary sinus elevation: A clinical cohort studyTiziano Testori, Riccardo Scaini, Matteo Deflorian, et al.
ACS Chemical Neuroscience|July 1, 2016
Identification of 2-({[1-(4-Fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)tricyclo[3.3.1.13,7]decane-2-carboxylic Acid (NTRC-844) as a Selective Antagonist for the Rat Neurotensin Receptor Type 2James B Thomas, Mélanie Vivancos, Angela M Giddings, et al.
Neuropharmacology|October 10, 2017
Fluorinated phenmetrazine "legal highs" act as substrates for high-affinity monoamine transporters of the SLC6 familyFelix P Mayer, Nadine V Burchardt, Ann M Decker, et al.
Journal of Medicinal Chemistry|October 14, 2009
Synthesis and biological evaluation of bupropion analogues as potential pharmacotherapies for cocaine addictionF Ivy Carroll, Bruce E Blough, Philip Abraham, et al.
The Prostate|August 27, 2019
Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancerFrank C Cackowski, Yugang Wang, Joseph T Decker, et al.
Pageof 9